ALPHA-5 INTEGRIN
Alpha-5 Integrin is a privately held preclinical-stage company that is developing monoclonal antibodies (mAbs) to treat amyotrophic lateral sclerosis.
Alpha-5 Integrin is a privately held preclinical-stage company that is developing monoclonal antibodies (mAbs) to treat amyotrophic lateral sclerosis.